Testing NHL Vaccines

" There are times when -- and offers up hope for instance that might change the course of the disease. Such as the case with non hodgkin's lymphoma. And a new vaccine therapy which doctors hope can -- missions and their survival."

" Therapy and radiation therapy that standard treatments can make it to tumor shrink and go away but it's temporary and eventually does come back. And the vaccine and we hope we'll keep it."

" No -- in lymphoma a cancer of the immune and is particularly suited to a vaccines and antibodies attack and help us an army. Everyone who only had east and -- about it. There's all cells that produce. Clones are all saying there can't. Be called an -- body idiot. And every patient has unique -- And so you have to sort of put a flag on an out of body recognized that goes Argentina and want to. We can take -- now we can pull out that you type in a body we can purify it. And we can get it back the work is an immune booster of like a vaccine. Immune system to go after the union's. It's fighting fire fire. What's innovative about the approach personalized immunotherapy. Is that the scene will be individualized. May be patient from his or her own tumor."

" It actually is the main street or. From their own tumor and it's only usable and that one -- So -- Maybe from their tumor. From their own tumor and given back in them and they only want to can benefit from this that make their."

" Or any new therapy a series of trials must be done that phase one -- a -- of a drug and we just look to see if it. -- is researching that drug I wouldn't doubt that we think that is safe based out of phase one. And look to see is there any evidence of activity. There -- these trials of vaccine immunotherapy. -- on going results from completed. Trials were very promising."

" We saw from those things to trial it. Can make you immune response against their own tumor. And it can it can international long time. And it even better than you can spot not all of them men in response the ones who do have -- seeing. Long time. Munitions --"

" The vaccines in the completed 32 trials are now in three to -- the final step before a drug is approved. Warns phase three trial sponsored by a company named genital and a second but the National Cancer Institute. "

" We have some people are getting. The vaccine that many listening from their own tumor on people getting something that looks and feels like the fact that doesn't contain the ingredients announcement. And -- comparing these two groups. To each other trying to prove that it actually -- an incumbent from coming back and people living longer."

" Patients are still being recruited pretty trials but only certain patients are eligible the current trials are looking at patient -- newly diagnosed. Molecular. Looking at the newly diagnosed so that they haven't been. -- for being beaten up with chemotherapy and adequate immune system we also like the hammer. Down to the minimum. That -- not. Two things you -- are looking at combining to being you know therapies antibody called her tucked in with the -- types are seen. This is an option for patients who don't respond as well they -- to chemotherapy. Who relapse or reason as their first treatment."

" The people who are political inadequate response in -- tumors shrink not enough or -- not long enough. And come back again give all of the patients retire. And treatment. To get their tumors. And then to -- them the vaccine."

" Patience in the -- pretrial treatment follows a standard and with an important to do -- We do require a biopsy -- to either surgical by a needle. If you go through chemotherapy after that chemotherapy standard routine in the same degree he -- that you weren't. -- recovery from their opinions. Are what are the vaccinations. Out argument is that China -- the skin like a diabetic himself insulin. That's been very well tolerated. In addition pace and take a drug called Ian -- as a continent can report it after each vaccination. Not this helps stimulate the immune. Districts from the vaccine -- are minimal he sometimes gets some redness and swelling -- on the site and inject him. Some people look at some flu like symptoms are muscle -- low grade fever. I'm otherwise it can -- tolerant. Once that vaccinations -- done -- politicians which is the interval we would do that -- or even bear to watch any signs of recurrent disease. I'm but without any further there. Yeah it's taking part in the trial doesn't mean abandoning other therapies if that does he returns to court in his. Even indexing close any door panel. And it doesn't. -- disease does however come packets at. They receive any -- their -- they would if they hadn't received acts there are also exciting possibilities about combining that -- seen with other therapies. And using it on -- more widespread basis."

" We would love to be able to combine an -- back scene with monoclonal antibody treatment type. Or -- they're -- but. We love to try it and other kinds. -- cell lymphoma and excellent and there's no reason to screen all abuse with aggressive than common. -- There's no reason that couldn't be used after transplantation. There's no reason it couldn't use that the first treatment. Instead of --"

" The development of the then he may or reaching implications. And the trial detest it are there for detonating the customized vaccines. A reality opening and we know what the therapy that people tend to disease. So why not try something. But many in the and hit the disease away longer perhaps Iraq. And -- every minute and a drug designed attack my typical. I'm my own pro. Of this. I'm hopeful -- oh well they are in the future some time. For more information on the clinical trials of eutectic -- non hodgkin's lymphoma. -- the lymphoma research foundation web site. At www. Than Loma dot org."